Our study expands the understanding of circRNA function in CRC pathogenesis, and the novel circEZH2/miR-133b/IGF2BP2/CREB1 axis may be a promising diagnostic marker and therapeutic target for CRC. Here, IGF2BP2 is linked to colorectal carcinoma.